GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Other Gross PPE

Celadon Pharmaceuticals (LSE:CEL) Other Gross PPE : €0.04 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Other Gross PPE?

Celadon Pharmaceuticals's Other Gross PPE for the quarter that ended in Dec. 2023 was €0.04 Mil.

Celadon Pharmaceuticals's quarterly Other Gross PPE increased from Dec. 2022 (€0.03 Mil) to Jun. 2023 (€7.31 Mil) but then declined from Jun. 2023 (€7.31 Mil) to Dec. 2023 (€0.04 Mil).

Celadon Pharmaceuticals's annual Other Gross PPE increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.03 Mil) and increased from Dec. 2022 (€0.03 Mil) to Dec. 2023 (€0.04 Mil).


Celadon Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Celadon Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Other Gross PPE Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
2.96 2.78 - 0.03 0.04

Celadon Pharmaceuticals Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Gross PPE Get a 7-Day Free Trial - 3.85 0.03 7.31 0.04

Celadon Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Celadon Pharmaceuticals (LSE:CEL) Business Description

Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines